U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H35O2.H4N
Molecular Weight 301.5078
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMMONIUM STEARATE

SMILES

[NH4+].CCCCCCCCCCCCCCCCCC([O-])=O

InChI

InChIKey=JPNZKPRONVOMLL-UHFFFAOYSA-N
InChI=1S/C18H36O2.H3N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h2-17H2,1H3,(H,19,20);1H3

HIDE SMILES / InChI

Molecular Formula H3N
Molecular Weight 17.0305
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C18H36O2
Molecular Weight 284.4772
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Stearic Acid is a typical example of a fatty acid, which are essentially long hydrocarbon chains containing a carboxyl group at one end and a methyl group at the other. The chain lengths can vary from 3 (propionic acid) to 24 (lignoceric acid) but the majority of fatty acids found in hydrogenated vegetable or animal oils are around C16-C20 in length. Stearic acid is a saturated acid, since there are no double bonds between neighbouring carbon atoms. Stearic acid is found in various animal and plant fats, and is a major component of cocoa butter and shea butter. Stearic acid is a very common amino acid is used in the manufacturing of more than 3,200 skin and hair care products sold in the United States. On product labels, it is sometimes listed under other names, including Century 1240, cetylacetic acid, Emersol 120, Emersol 132, Emersol 150, Formula 300 and Glycon DP. Stearic Acid is mainly used in the production of detergents, soaps, and cosmetics such as shampoos and shaving cream products. Stearic acid is used along with castor oil for preparing softeners in textile sizing. Being inexpensively available and chemically benign, stearic acid finds many niche applications It is used in the manufacture of candles, and as a hardener in candies when mixed with simple sugar and corn syrup. It is also used to produce dietary supplements. In fireworks, stearic acid is often used to coat metal powders such as aluminum and iron. This prevents oxidation, allowing compositions to be stored for a longer period of time. Stearic acid is a common lubricant during injection molding and pressing of ceramic powders. It is also used as a mold release for foam latex that is baked in stone molds. Stearic acid is known antidiabetic and antioxidant agent.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
9.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Preventing
CELLBN First care cleanser

Approved Use

Unknown

Launch Date

2017
Preventing
MARY KAY TIMEWISE REPAIR VOLU-FIRM THE GO SET

Approved Use

Uses: helps prevent sunburn if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Launch Date

2017
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG



OverviewOther

Other InhibitorOther SubstrateOther Inducer



Drug as perpetrator​
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Distribution of vitamin A-storing lipid droplets in hepatic stellate cells in liver lobules--a comparative study.
2003-03
Further investigations into the use of high sensitivity differential scanning calorimetry as a means of predicting drug-excipient interactions.
2003-02-18
Spray-dried chitinosans. Part II: in vitro drug release from tablets made from spray-dried chitinosans.
2003-02-18
Duration of coffee- and exercise-induced changes in the fatty acid profile of human serum.
2003-02
Percutaneous absorption of inorganic lead compounds.
2003-01-18
Chitinosan-drug complexes: effect of electrolyte on naproxen release in vitro.
2003-01-02
The influence of lipid nanocapsule composition on their size distribution.
2003-01
Binding of [99mTc]chondroitin sulfate to scavenger receptors on human chondrocytes as compared to binding of oxidized [125I]LDL on human macrophages.
2002-12-31
Different role of saturated and unsaturated fatty acids in beta-cell apoptosis.
2002-12-20
A case of rhinolithiasis in botswana: a mineralogical, microscopic and chemical study.
2002-12
Synthesis and selectin-binding activity of N-deacetylsialyl Lewis X ganglioside.
2002-11-19
Fatty acid mobilized by the vascular endothelial growth factor in human endothelial cells.
2002-11
Purification and characterization of a novel cholesterol esterase from Pseudomonas aeruginosa, with its application to cleaning lipid-stained contact lenses.
2002-11
Roller compaction and tabletting of St. John's wort plant dry extract using a gap width and force controlled roller compactor. II. Study of roller compaction variables on granule and tablet properties by a 3(3) factorial design.
2002-11
Roller compaction and tabletting of St. John's wort plant dry extract using a gap width and force controlled roller compactor. I. Granulation and tabletting of eight different extract batches.
2002-11
Formulation and stability evaluation of ketoprofen sustained-release tablets prepared by fluid bed granulation with Carbopol 971P solution.
2002-11
Development of polymer film dosage forms of lidocaine for buccal administration: II. Comparison of preparation methods.
2002-11
Rheological properties of three component creams containing sorbitan monoesters as surfactants.
2002-10-24
Molecular species of PC and PE formed during castor oil biosynthesis.
2002-10
Compatibility between active components of a commercial drug.
2002-10
Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".
2002-10
Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects.
2002-10
Fatty acids carried on albumin modulate proximal tubular cell fibronectin production: a role for protein kinase C.
2002-10
Inverse gas chromatography study on partially esterified paper fiber.
2002-09-06
Mass spectrometric analysis of GAP-43/neuromodulin reveals the presence of a variety of fatty acylated species.
2002-09-06
Mixing of cohesive pharmaceutical formulations in tote (bin) blenders.
2002-09
Design of controlled release system with multi-layers of powder.
2002-09
Influence of physical parameters and lubricants on the compaction properties of granulated and non-granulated cross-linked high amylose starch.
2002-09
Sonolysis of surfactants in aqueous solutions: an accumulation of solute in the interfacial region of the cavitation bubbles.
2002-09
Surface damage in machined ram-extruded and net-shape molded retrieved polyethylene tibial inserts of total knee replacements.
2002-09
Study of the stability of tablets containing 10 mg of policosanol as active principle.
2002-08-29
Molecular species of acylglycerols incorporating radiolabeled fatty acids from castor (Ricinus communis L.) microsomal incubations.
2002-08-28
Long-chain fatty acid uptake and oxidation in the perfused liver of Walker-256 tumour-bearing rats.
2002-08
Effect of formulation variables on the floating properties of gastric floating drug delivery system.
2002-08
3-nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: implications for Huntington's disease.
2002-06
Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation.
2002-05-15
Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
2002-05
Pancreatic beta-cell alpha2A adrenoceptor and phospholipid changes in hyperlipidemic rats.
2002-05
Geoglobus ahangari gen. nov., sp. nov., a novel hyperthermophilic archaeon capable of oxidizing organic acids and growing autotrophically on hydrogen with Fe(III) serving as the sole electron acceptor.
2002-05
The apoplastic oxidative burst in response to biotic stress in plants: a three-component system.
2002-05
Dietary cholesterol modulates delta6 and delta9 desaturase mRNAs and enzymatic activity in rats fed a low-eFA diet.
2002-04
Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans.
2002-04
Effect of nitrosylmyoglobin and saturated fatty acid anions on metmyoglobin-catalyzed oxidation of aqueous methyl linoleate emulsions.
2002-03-15
Comparison of effects of cholecystokinin and erythromycin on bile chemistry and gallstone formation in aged guinea pigs.
2002-03-02
The effects of some physico-chemical factors and pharmaceutical excipients on the bioavailability of nitrofurantoin oily and aqueous suspensions in rats.
2002-03
Design of Peumus boldus tablets by direct compression using a novel dry plant extract.
2002-02-21
Computerized posturography with sway frequency analysis: application in occupational and environmental health.
2002-01
[Effect of magnesium stearate on the tensile strength of tablets made with the binder Prosolv SMCC 90].
2002-01
Content of retinol and retinyl esters in blood plasma, liver, kidney and reproductive organs of Japanese quails.
2002
Food-drug interactions.
2002
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: When these same investigators used a lower amount of dietary stearic acid (i.e., an increase of 3 g/day using milk chocolate) in a similar study, no differences in platelet aggregation or platelet activation activity were found
A stearic acid-rich diet (~ 7% of calories or 19 g/day) had beneficial effects on several measures of thrombosis (e.g., platelet volume, platelet aggregation, coagulation factor VII activity) in healthy males. Stearic acid was increased by 12 g/day using stearic acid-enriched margarine.
Route of Administration: Oral
Inhibition of EDR (endothelium-dependent relaxation) induced by acetylcholine was dose-dependent (0.5-2 mmol/l NEFA), and the greatest inhibition (51%) was observed with stearic acid (2 mmol/l).
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:11:01 GMT 2025
Edited
by admin
on Mon Mar 31 18:11:01 GMT 2025
Record UNII
37899330TZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMMONIUM STEARATE
INCI   MI  
INCI  
Official Name English
AMMONIUM STEARATE [MI]
Preferred Name English
NOPCOTE DC 100A
Common Name English
OCTADECANOIC ACID, AMMONIUM SALT
Common Name English
VICARLAN BA
Common Name English
STEARIC ACID, AMMONIUM SALT
Common Name English
INS-470(I)STEARIC ACID, AMMONIUM SALT
Common Name English
LIGAFLUID AS 35
Common Name English
STANFAX 320
Common Name English
E-470(I)STEARIC ACID, AMMONIUM SALT
Common Name English
INS NO.470(I)STEARIC ACID, AMMONIUM SALT
Common Name English
STOKAL STA
Common Name English
KANEBINOL YC 81
Common Name English
Classification Tree Code System Code
CODEX ALIMENTARIUS (GSFA) INS-470(I)
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
JECFA EVALUATION INS-470(I)
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
Code System Code Type Description
MERCK INDEX
m1820
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID0027353
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY
PUBCHEM
61251
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY
DAILYMED
37899330TZ
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY
RXCUI
1312975
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY RxNorm
ECHA (EC/EINECS)
213-695-2
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY
CAS
1002-89-7
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY
FDA UNII
37899330TZ
Created by admin on Mon Mar 31 18:11:01 GMT 2025 , Edited by admin on Mon Mar 31 18:11:01 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE